---
title: "West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287972975.md"
description: "West Pharmaceutical Services Inc. (WST) shares rose 2.91% to $321.80, outperforming competitors on a strong trading day. The S&P 500 Index increased by 0.58%, while the Dow Jones Industrial Average saw a slight rise of 0.05%. Despite the gain, WST remains 2.74% below its 52-week high of $330.88. Trading volume was 772,706, below the 50-day average of 884,181."
datetime: "2026-05-28T21:05:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287972975.md)
  - [en](https://longbridge.com/en/news/287972975.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287972975.md)
---

# West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) advanced 2.91% to $321.80 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.58% to 7,563.63 and the Dow Jones Industrial Average rising 0.05% to 50,668.97.

The stock's rise snapped a two-day losing streak.

West Pharmaceutical Services Inc. closed 2.74% below its 52-week high of $330.88, which the company reached on May 11th.

The stock outperformed some of its competitors Thursday, as Abbott Laboratories (ABT) rose 0.72% to $86.30, Becton Dickinson & Co. (BDX) rose 0.79% to $148.41, and Baxter International Inc. (BAX) fell 0.41% to $19.25.

Trading volume (772,706) remained 111,475 below its 50-day average volume of 884,181.

Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-28-26 1705ET

### Related Stocks

- [WST.US](https://longbridge.com/en/quote/WST.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [BDX.US](https://longbridge.com/en/quote/BDX.US.md)
- [BAX.US](https://longbridge.com/en/quote/BAX.US.md)

## Related News & Research

- [West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/287315534.md)
- [Northwestern Mutual Wealth Management Co. Has $4.51 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/287454800.md)
- [Madrigal Pharmaceuticals Says Data Show Rezdiffra Reduces Cardiovascular, Liver-Related Risks in MASH Patients](https://longbridge.com/en/news/287790915.md)
- [Madrigal Pharmaceuticals Insider Sold Shares Worth $2,928,716, According to a Recent SEC Filing](https://longbridge.com/en/news/287601626.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)